Table 2.
Barriers by Number of Occurrences
Number of barriers | Barriers | Frequency | Percent |
---|---|---|---|
1 | Process changes | 7 | 23 % |
2 | High levels of training required | 4 | 13 % |
3 | Efficacy – no universal definition of medication error which makes studies difficult to compare | 3 | 10 % |
4 | No universal CPOE solution | 2 | 6 % |
5 | CPOE is complex | 2 | 6 % |
6 | Cost | 2 | 6 % |
7 | Level of adoption / variance | 2 | 6 % |
8 | Poor user interface | 2 | 6 % |
9 | CPOE eliminates some error, but introduces new error | 1 | 3 % |
10 | Resistance of clinicians due to the perception of loss of autonomy | 1 | 3 % |
11 | Legal concerns | 1 | 3 % |
12 | Lack of adequate staffing | 1 | 3 % |
13 | Can take years to realize decrease in error | 1 | 3 % |
14 | Complexity of the medication | 1 | 3 % |
15 | Successful implementation requires strong leadership endorsement | 1 | 3 % |
Total instances of barriers | 31 |